细胞疗法 SCIE

期刊简介预计审稿时间： 偏慢,4-8周

The journal brings readers the latest developments in the fast moving field of cellular therapy in man. This includes cell therapy for cancer, immune disorders, inherited diseases, tissue repair and regenerative medicine. The journal covers the science, translational development and treatment with variety of cell types including hematopoietic stem cells, immune cells (dendritic cells, NK, cells, T cells, antigen presenting cells) mesenchymal stromal cells, adipose cells, nerve, muscle, vascular and endothelial cells, and induced pluripotential stem cells. We also welcome manuscripts on subcellular derivatives such as exosomes. A specific focus is on translational research that brings cell therapy to the clinic. Cytotherapy publishes original papers, reviews, position papers editorials, commentaries and letters to the editor. We welcome "Protocols in Cytotherapy" bringing standard operating procedure for production specific cell types for clinical use within the reach of the readership.

该期刊为读者带来快速发展的人类细胞治疗领域的最新进展。这包括癌症、免疫疾病、遗传疾病、组织修复和再生医学的细胞治疗。该期刊涵盖各种细胞类型的科学、转化发展和治疗，包括造血干细胞、免疫细胞（树突状细胞、NK 细胞、T 细胞、抗原呈递细胞）、间充质基质细胞、脂肪细胞、神经、肌肉、血管和内皮细胞以及诱导性多能干细胞。我们也欢迎有关亚细胞衍生物（如外泌体）的手稿。特别关注将细胞疗法带入临床的转化研究。Cytotherapy 发表原创论文、评论、立场文件社论、评论和致编辑的信。我们欢迎“细胞治疗协议”，为读者提供用于临床生产特定细胞类型的标准操作程序。

《Cytotherapy》(细胞疗法)编辑部通讯方式为TAYLOR & FRANCIS AS, KARL JOHANS GATE 5, OSLO, NORWAY, NO-0154。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。